Cargando…
Health Economic Assessment: Cost-Effectiveness Thresholds and Other Decision Criteria
An article published in this Journal argued that New Zealand does not apply a cost-effectiveness threshold because medicines are funded within a fixed budget and because cost-effectiveness is only one of nine criteria that inform decisions. This Comment has explained that, from a theoretical perspec...
Autor principal: | Simoens, Steven |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872336/ https://www.ncbi.nlm.nih.gov/pubmed/20617062 http://dx.doi.org/10.3390/ijerph7041835 |
Ejemplares similares
-
Reply to Standaert, B. Comment on “Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium”
por: Postma, Maarten J., et al.
Publicado: (2023) -
Criteria to Assess a Randomized Controlled Pilot Study: Response to Letter
por: Oveisi, Sonia
Publicado: (2013) -
A Flexible Lockdown by Integrating Public Health and Economic Reactivation to Response the Crisis of COVID-19: Responses to Comments by Alvaro J Idrovo on “An Examination on the Transmission of COVID-19 and the Effect of Response Strategies: A Comparative Analysis”
por: Chen, Yi-Tui, et al.
Publicado: (2020) -
Does health technology assessment compromise access to pharmaceuticals?
por: Büssgen, Melanie, et al.
Publicado: (2023) -
Reply to commentary on costs of diabetes and its complications in Poland
por: Leśniowska, Joanna
Publicado: (2014)